Cincinnati—University of Cincinnati Medical Center Senior Vice
President and Provost for Health Affairs Donald C. Harrison, MD, today
announced his support for the proposal to allocate a significant share
of Ohio's Tobacco Settlement funds for biomedical research.
a substantial portion of the tobacco settlement funds to biomedical
research would be a smart investment for Ohio," states Harrison.
"Tobacco-related diseases account for more than 400,000 deaths each
year. The settlement funds can support new and ongoing research to help
find the causes and cures of these deadly diseases.
Cincinnati, the increase will help in the city's efforts to be a leader
in the biomedical sciences industry," says Harrison. "The funds can
serve to attract additional researchers and research positions in the
area, strengthening the Tristate's economy.
support at the state level may also lead to an increase in federal
research funds," explains Harrison. "It is anticipated that the
National Institutes of Health (NIH) will have additional research funds
in the years ahead. To receive these funds, Ohio's medical institutions
need modern laboratories and equipment to attract leading researchers
who will receive these grants."
UC Medical Center already enjoys
a strong reputation in the field of biomedical research. In 1998, it
received $118 million in federal research grants, and three departments
in the College of Medicine rank in the top 10 by the National
Institutes of Health, including Molecular Genetics, Environmental
Health, and Obstetrics/Gynecology. The Carnegie Commission has
designated UC as a Research I University, an honor shared by only 75 of
the 5,000 higher education institutions in the country.
the UC Medical Center joined a coalition of Ohio's biomedical research
institutions voicing support for a plan presented to Ohio's Tobacco
Settlement Task Force by the Ohio Office of Budget & Management.